Clinical Trials Logo

Clinical Trial Summary

Acute limb ischemia is one of the devastating vascular emergencies that lead to life and limb loss if the appropriate treatment is not reached.The revascularization is a cornerstone in treating acute limb ischemia. The conventional surgical approach includes surgical embolectomy and surgical bypass.From the anesthetic aspect, this emergency condition limits the lengthening cardiovascular assessment of this high-risk patient group which might lead to the uncertainty outcome.With the variety of patients and procedures, we sought to find out the perioperative adverse events, especially major adverse cardiac events, in acute ischemic limb patients undergoing revascularization, in order to increase awareness of the team and properly admit to ICU in a retrospective manner.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05362266
Study type Observational
Source Mahidol University
Contact Tachawan Jirativanont, MD
Phone +66816422817
Email tachawan.jir@mahidol.acth
Status Recruiting
Phase
Start date April 10, 2022
Completion date April 1, 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT04139655 - Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study N/A
Completed NCT01780727 - Echo-guided Hemodynamic Management Strategy in Elderly Patients Undergoing Noncardiac Surgery N/A
Not yet recruiting NCT06037759 - Novel Cardiovascular Biomarkers in Patients With Kidney Disease
Not yet recruiting NCT06386445 - Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT: Cohort Study
Recruiting NCT06391632 - Construction of a Prediction Model for MACCE in Elderly Patients After Elective Non-cardiac Surgery
Not yet recruiting NCT06060483 - Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis N/A
Not yet recruiting NCT06108414 - Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation Phase 4
Completed NCT03793582 - Impact of OSA on Outcomes in Acute Coronary Syndrome